Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Discovery and development of novel therapies to treat diseases caused by protein dysregulation135.16M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States135.16M100.00%